Trevi Therapeutics Announces Two Presentations on the Phase

/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...

Related Keywords

Washington , United States , American , Toby Maher , Rosalia Scampoli , Katie Mcmanus , Linkedin , University Of Southern California , International Conference , Trevi Therapeutics Inc , Nasdaq , Keck School Of Medicine , American Thoracic Society , Keck School , Trevi Therapeutics , Emerging Data , Symptom Based Therapeutics , Interstitial Lung Disease , Chronic Cough , Idiopathic Pulmonary , Nc ,